Status:

UNKNOWN

Aerobic Training Effects on Motor and Cognitive Performances in MS: an Exploratory Study With Structural and Functional MRI

Lead Sponsor:

IRCCS San Raffaele

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Aerobic training (AT) induces cardiovascular, metabolic and muscular changes and has been proposed as a promising rehabilitative approach in elderly adults and in neurological patients to improve both...

Detailed Description

This study is a monocentric, non-pharmacological, longitudinal, randomized, blind, controlled study. Subjects The Investigators will study 40 right-handed MS patients with Expanded Disability Status ...

Eligibility Criteria

Inclusion

  • Inclusion criteria (All)
  • Age between 18 and 65 years;
  • Native italian language speaking;
  • Right-handed;
  • No particular motor skills;
  • No additional neurologic, psychiatric, orthopaedic or rheumatologic diseases;
  • Normal or corrected-to-normal vision;
  • No contraindications to MRI;
  • Ability to understand the purpose of the study and provide signed informed consent.
  • For MS patients, the following additional inclusion criteria will be applied:
  • Patients with a diagnosis of MS, regardless of sex, duration and course of the disease;
  • EDSS score ranging from 0 to 6.0 (included);
  • Stable treatment for MS from at least 1 month prior to study enrolment;
  • Relapse- and steroid-free from at least 3 months before screening visit;
  • An indication to perform a physiotherapy treatment by the treating physician.
  • Exclusion Criteria:
  • Persons who perform regularly a structured training;
  • Patients who performed a physiotherapy treatment for at least 3 months;
  • Concomitant therapy with antidepressant, baclofen, psychoactive, and steroids drugs as well as symptomatic treatment for fatigue;
  • History of alcohol or substance abuse;
  • Pregnancy or breastfeeding.

Exclusion

    Key Trial Info

    Start Date :

    June 13 2015

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2024

    Estimated Enrollment :

    80 Patients enrolled

    Trial Details

    Trial ID

    NCT04097418

    Start Date

    June 13 2015

    End Date

    December 31 2024

    Last Update

    September 28 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    IRCCS San Raffaele

    Milan, Italy, 20132